Ong, Janus P <br/><br/>
Managing the hematologic side effects of antiviral therapy for chronic hepatitis C: anemia, neutropenia, and thrombocytopenia.  [electronic resource] 

 -  Cleveland Clinic journal of medicine  May 2004 
 - S17-21 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0891-1150 
<br/><br/><label>Standard No.: </label>10.3949/ccjm.71.suppl_3.s17  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anemia--chemically induced<br/>Antiviral Agents--administration & dosage<br/>Clinical Trials as Topic<br/>Darbepoetin alfa<br/>Drug Therapy, Combination<br/>Epoetin Alfa<br/>Erythropoietin--administration & dosage<br/>Filgrastim<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Interferons--administration & dosage<br/>Interleukin-11--administration & dosage<br/>Neutropenia--chemically induced<br/>Patient Compliance<br/>Polyethylene Glycols--administration & dosage<br/>Quality of Life<br/>Randomized Controlled Trials as Topic<br/>Recombinant Proteins--administration & dosage<br/>Ribavirin--administration & dosage<br/>Thrombocytopenia--chemically induced